Note: Ingredients listed on restricted chemical lists
EC/CAS
232-142-6/7789-06-2
Name of the chemical
Strontium chromate
Concentration
≥10-≤24
EC/CAS
238-878-4/14808-60-7
Name of the chemical
Silica, crystalline
Concentration
≥10-≤25
EC/CAS
203-550-1/108-10-1
Name of the chemical
4-methylpentan-2-one; isobutyl methyl ketone (MIBK)
Concentration
≤10
EC/CAS
500-033-5/25068-38-6
Name of the chemical
4,4'-Isopropylidenediphenol, oligomeric reaction products with 1-chloro-2,3-epoxypropane
Concentration
≤10
EC/CAS
239-701-3/15625-89-5
Name of the chemical
2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate; 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate
Concentration
≤3
EC/CAS
203-625-9/108-88-3
Name of the chemical
Toluene
Concentration
<1
EC/CAS
204-617-8/123-31-9
Name of the chemical
1,4-Dihydroxybenzol (790/2009)
Concentration
≤0.015
General Information
Revision date
2022-01-02
Product name
High Solids Epoxy Primer 10P20-44
1.2.1 Relevant identified uses
Aerospace coating
1.2.2. Uses advised against
Reason
Emergency telephone
31 (0)71 308 6944
Icons in SDS
Company Information
company name
AkzoNobel Aerospace Coatings
e-mail address of the competent person responsible for the Safety Data Sheet
PSRA_SSH@akzonobel.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H302, H315, H317, H319, H350, H372, H411
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Danger
Hazard statements
Highly flammable liquid and vapor. Harmful if swallowed. Causes serious eye irritation. Causes skin irritation. May cause an allergic skin reaction. May cause cancer. Causes damage to organs through prolonged or repeated exposure. Toxic to aquatic life with long lasting effects.
Prevention
Obtain special instructions before use. Wear protective gloves. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Do not breathe vapor.
Response
IF exposed or concerned: Get medical attention.
Storage
Not applicable.
Disposal
Not applicable.
Hazardous Ingredients
strontium chromate heptan-2-one crystalline silica, respirable powder Oxirane, 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-, homopolymer reaction product: bisphenol-A-(epichlorhydrin); epoxy resin Phenol, polymer with formaldehyde, glycidyl ether 2,2-bis(acryloyloxymethyl)butyl acrylate
Supplemental label elements
Contains epoxy constituents. May produce an allergic reaction.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Restricted to professional users. Authorization number (Annex XIV Reg. 1907/2006, REACH) strontium chromate : REACH/20/7/10 (application of primers and specialty coatings) REACH/20/7/0 (formulation of mixtures)
Special packaging requirements
Date of issue/Date of revision 2/1/2022 Date of previous issue 1/18/2022 Version 18. 2/18 32 Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Other hazards which do : None known. not result in classification The mixture may be a skin sensitizer. It may also be a skin irritant and repeated contact may increase this effect.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Flam. Liq. 2, H225 Acute Tox. 4, H302 Skin Irrit. 2, H315 Eye Irrit. 2, H319 Skin Sens. 1, H317 Carc. 1B, H350 STOT RE 1, H372 Aquatic Chronic 2, H411 Date of issue/Date of revision : 2/1/2022 Date of previous issue : 1/18/2022 Version : 18. 1/18 32 SECTION 2: Hazards identification The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. Ingredients of unknown : 5.3 percent of the mixture consists of component(s) of unknown toxicity toxicity See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
